A Michigan Medicine hypertension specialist, who was part of the team behind the newly released high blood pressure recommendations, explains what’s changed.
A new study examining allocations of NIH research dollars finds lagging support for cardiac arrest, which kills hundreds of thousands of Americans each year.
From moderate-risk TAVR to PCSK9 inhibitors to exercise in HCM, the American College of Cardiology’s annual Scientific Session brought advancements across many areas of cardiology.
A modestly sized clinical trial indicates that PCSK9-inhibitors can help lower cholesterol, even for those who experienced side effects with older drugs.
Wearable devices can help individuals adopt healthy habits, preliminary research has found. In the future, they will become even more important tools.